NEWS ROOM

See the latest news from our company below or use the search feature. For more information, contact our head office or the Marketing Communications Manager directly at marcom@arazygroup.com.


 

  • SHORTER REGISTRATION TIME IN MEXICO

    Nov 07, 2014
    Arazy Group offers an option to dramatically shorten registration times in Mexico, where medical device manufacturers can wait as long as two years for medical device license approval.
    Full story
  • ONE YEAR AFTER ITS LAUNCH: A NEW LICENSING PLATFORM DELIVERS UNPRECEDENTED RESULTS FOR MEDICAL DEVICE MANUFACTURERS

    Nov 07, 2014
    Vancouver, Canada (September 16th 2013) – A case study released on the anniversary of medical device giant Elekta’s work with LICENSALE.COM™ revealed that just one year after its launch, Arazy Group’s unique, online registration platform is a revolutionary regulatory asset for medical device manufacturers of all sizes. Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. Like many other manufacturers, Elekta previously focused mainly on major markets, including Europe, North America, and countries like Brazil and China.
    Full story
  • VISIT US AT RAPS 2013

    Nov 07, 2014
    Visit us at RAPS 2013 from September 28th to October 2nd! Contact us to set up a meeting at info@arazygroup.com.
    Full story
  • ARAZY GROUP ANNOUNCES PARTNERSHIP WITH TOXIKON CORPORATION

    Nov 07, 2014
    Vancouver, BC (April 24, 2013) – Leading regulatory consultancy Arazy Group Consultants Inc. and Toxikon, one of the world’s premier accredited research and testing facilities, announced today the formation of a partnership. The cooperation between the two companies will begin as Arazy Group introduces Toxikon’s services to other global markets, starting with Israel.
    Full story
  • REGULATORY UPDATE: RUSSIA

    Nov 07, 2014
    APRIL 2013, RUSSIA: Leading USA manufacturer of CPR, defibrillator, and other life-saving equipment received clearance from Russian authorities.
    Full story
  • REGULATORY UPDATE: CROMA PHARMA

    Nov 10, 2014
    APRIL 2013, ARGENTINA: CROMA PHARMA's SYNOCROM® a high quality viscosupplementation device for the treatment of osteoarthritis was approved for sale in Argentina. For any information contact CROMA´s headquater email: fleischmann@croma.at.
    Full story
  • REGULATORY UPDATE: GLOBAL INSTRUMENTATION

    Nov 07, 2014
    APRIL 2013, PERU: Global Instrumentation's M12 Matrix Holter System has been approved for sale.
    Full story
  • ARAZY GROUP OPENS NEW OFFICE IN GERMANY

    Nov 07, 2014
    Arazy Group officially opened an office in Germany today. For more information please contact germany@arazygroup.com.
    Full story
  • REPORT ON ANVISA B-GMP INSPECTION REGIME

    Nov 10, 2014
    This is to report on the current situation regarding B-GMP (or “BPF”) certification by ANVISA. This regime came into effect on 22 May 2010. After this resolution was published in May 2009 there was widespread concern about ANVISA´s capacity to audit manufacturers all over the world. Now it is obvious that ANVISA does not have the resources to inspect manufacturers within the time frame established by law, which theoretically should more than 90 days after being required, but actually delays well over 6 months take place.
    Full story
  • REGULATORY UPDATE: UMF

    Nov 10, 2014
    MARCH 2013, SAUDI ARABIA: UMF's line of treatment tables have been approved for sale.
    Full story
  • REGULATORY UPDATE: EYETECH

    Nov 10, 2014
    MARCH 2013, EU: EyeTech’s Eye movement analysis systems, TM4 and TM4 mini, were approved for sale in European Union. Register your device now with LICENSALE.COM™.
    Full story
  • ARAZY GROUP SELECTED AS TOP INNOVATOR THROUGH SELECTION FOR THE CANADIAN TECHNOLOGY ACCELORATOR PROGRAM

    Nov 10, 2014
    Vancouver, B.C. (March 14 2013) – The Government of Canada announced this week that medical device consultancy Arazy Group is one of eight companies selected to participate in the Canadian Technology Accelerator program, which connects ground-breaking Canadian companies with the Cambridge Innovation Center in Boston, Massachusetts.
    Full story
  • ARAZY GROUP OPENS LICENSALE™ HQ IN SAN FRANCISCO

    Nov 07, 2014
    On March 1st, Arazy Group opened our new headquarters for LICENSALE™ in San Francisco, California.
    Full story
  • REGULATORY UPDATE: ULTRASONIX

    Nov 10, 2014
    FEBRUARY 2013, EU: Ultrasonix's SonixGPS™ Needle Sensors, SonixGPS™ Nerve Block Needle Kits, and SonixGPS™ Vascular Access Needle Kits have been approved for the sale in the European Union.
    Full story
  • UPDATE ON MEDICAL DEVICE PRODUCT REGISTRATION TURN-AROUND-TIME FOR SINGAPORE

    Nov 10, 2014
    With the implementation of the Medical Device Regulations since August 2010, HSA has been experiencing a very high volume of product registration applications for all device categories. Despite the Arazy Group ramping up capacity to meet this high volume, the higher volume and complexity of products being submitted for application have resulted in processing times being longer than the current published turn-around-time (TAT).
    Full story
  • MEXICO | THE SECRETARY OF HEALTH, SALOMON CHERTORIVSKI ANNOUNCES EQUIVALENCE AGREEMENT WITH JAPAN FOR MEDICAL DEVICES

    Nov 10, 2014
    The goal is to expand the supply of Japanese leading-edge medical equipment to Mexicans and strengthen the competitiveness of the economy.
    Full story
  • LATEST NEWS FROM US-FDA CENTER FOR DEVICES AND RADIOLOGICAL HEALTH | 10 JULY 2012

    Nov 10, 2014
    Today, President Obama signed the FDA Safety and Innovation Act (FDASIA). This law includes the Medical Device User Fee Amendments of 2012 (MDUFA III) as well as other medical device provisions. MDUFA III will be in effect for five years beginning October 1, 2012. It includes performance goals and user fees paid to the Food and Drug Administration (FDA) by medical device companies when they register and list with the FDA and when they submit an application to market a medical device in the U.S.
    Full story
  • REGULATORY UPDATE: MEDXL

    Nov 10, 2014
    JANUARY 2013, TURKEY: MedXL prefilled syringes have been licensed for sale in Turkey. Register your medical devices online with LICENSALE.COM™.
    Full story
  • REGULATORY UPDATE: 3SHAPE

    Nov 10, 2014
    JANUARY 2013, TURKEY: 3Shape’s intra oral scanners have been approved for sale in Turkey. Register your devices with LICENSALE.COM™ -- request a free quote today.
    Full story
  • REGULATORY UPDATE: OPHTHALMIC DEVICES

    Nov 10, 2014
    DECEMBER 2012, SAUDI ARABIA: Ophthalmic Devices successfully registers with the SFDA, following registration of their ophthalmic medical devices in South Africa, Thailand, and others.
    Full story
latest news
  • Sep 19 2017
    REGULATORY UPDATE - SPD

    Korea: SPD's CB11 was approved for sale with LICENSALE.COM®. ...

    Read More
  • Sep 6 2017
    REGULATORY UPDATE - SPD

    Philippines: SPD's IVD products CBDOT were approved for sale with LICENSALE.COM®. ...

    Read More
  • Aug 31 2017
    REGULATORY UPDATE - CORTEX

    USA: Cortex's Dental implants and Prosthetic Devices were approved for sale with LICENSALE.COM®...

    Read More
  • Aug 10 2017
    REGULATORY UPDATE - SPD

    Ethiopia: SPD's CB11, CB9 & CBDOT were approved for sale with LICENSALE.COM®. ...

    Read More
  • Aug 8 2017
    REGULATORY UPDATE - XERIDIEM

    Saudi Arabia: Xeridiems' Entuit family was approved for sale with LICENSALE.COM®. ...

    Read More

VANCOUVER OFFICE

  • Phone +1 604.681.6888
  • Fax +1 604.681.6822
  • info@arazygroup.com
  •  
  • #350-1333 Johnston Street
  • Pier 32, Granville Island
  • Vancouver, British Columbia
  • Canada V6H 3R9

BACK TO TOP